Crimean-Congo hemorrhagic fever virus (CCHFV) does not behave as a single, uniform biological entity. Although all known isolates belong to the same highly pathogenic virus species, differences in their genomes can influence replication, tissue damage, immune evasion and the severity of disease. A new study by Rohde, Werner, Gellhorn Serra and colleagues provides a direct comparison of two CCHFV isolates in a genetically defined mouse model, offering a closer look at how viral variation can shape experimental outcomes.
Published in npj Viruses, the study examines the viruses in mice lacking the type I interferon receptor, known as IFNAR−/− mice. Type I interferons, including interferon-alpha and interferon-beta, are among the body’s earliest antiviral defenses. They activate hundreds of genes that restrict viral replication and help coordinate innate and adaptive immunity. By removing the receptor required for cells to respond to these signals, researchers create an animal model that is highly vulnerable to CCHFV infection and can support the development of severe disease.
The use of IFNAR−/− mice is particularly important for studying CCHFV because ordinary laboratory mice often resist infection or develop disease that does not reproduce the rapid progression seen in humans. The model does not replicate every feature of human Crimean-Congo hemorrhagic fever, but it allows researchers to compare viral isolates under controlled conditions. A side-by-side design also reduces the risk that differences in housing, timing, animal age or experimental handling will be mistaken for genuine differences between viruses.
Rohde and colleagues evaluated the two isolates using a combination of clinical and virological measurements. Such assessments typically include changes in body weight, temperature or activity, the onset and progression of disease signs, survival, viral RNA levels in blood and organs, and microscopic evidence of tissue injury. Together, these measurements distinguish between viruses that replicate efficiently, viruses that spread to particular organs, and viruses that cause severe disease even when their overall quantities are similar.
The comparison demonstrates why the isolate used in an animal experiment can be a decisive variable. Closely related CCHFV isolates may differ in the speed at which they establish infection, the extent to which they disseminate through the body and the severity of the resulting pathology. Differences can arise from mutations affecting viral replication, interactions with host proteins, the ability to counter innate immune responses or the balance between viral growth and inflammatory injury. These effects may not be apparent when experiments are conducted with only one strain.
CCHFV is an enveloped, negative-sense RNA virus in the family Nairoviridae. Its genome is divided into three segments that encode structural and non-structural proteins, including the nucleoprotein, the surface glycoprotein precursor and an RNA-dependent RNA polymerase. The segmented genome creates opportunities for genetic reassortment when different viruses infect the same cell, while the error-prone nature of RNA replication generates additional diversity. This biological flexibility helps explain why isolates collected in different regions or hosts can show distinct phenotypes in laboratory systems.
The study’s findings have consequences beyond the immediate comparison. Animal models are widely used to evaluate vaccines, antibody treatments, antiviral compounds and supportive-care strategies. If two isolates produce different disease trajectories in the same mouse background, a treatment that appears effective against one virus may not perform identically against another. Conversely, a model based on an especially aggressive isolate could make an intervention appear less effective than it would be against a broader range of circulating viruses. Careful strain selection and transparent reporting are therefore essential for reproducible CCHFV research.
The work also highlights the limitations of relying on a single laboratory model. IFNAR−/− mice lack a central component of antiviral immunity, and their response to infection cannot be directly equated with the response of people, whose disease is influenced by age, genetics, prior immune activation, coagulation pathways and other factors. The model is nevertheless valuable because it provides a consistent framework for comparing viruses and identifying mechanisms that can later be tested in more complex systems, including immune-competent animals, organoid cultures and human clinical samples.
For public-health researchers, the study reinforces the importance of treating CCHFV as a genetically diverse threat rather than as one standardized pathogen. The virus is maintained in nature through cycles involving ticks and animal hosts, and human infections occur across a broad geographic range. Surveillance programs that sequence viruses and link genetic data with clinical information may help determine whether particular viral lineages are associated with altered transmissibility or disease severity. The side-by-side approach used in this study offers a practical foundation for connecting viral genotype with biological behavior.
By placing two isolates under identical experimental conditions, the researchers provide a clearer framework for interpreting virulence studies and for designing future countermeasure trials. The broader message is that model systems are only as informative as the viral strains selected for them. As CCHFV research expands, comparisons across multiple isolates, host backgrounds and immune conditions will be critical for identifying results that are truly generalizable. The study therefore contributes not only to understanding these two viruses, but also to a more rigorous strategy for investigating one of the world’s most serious tick-borne viral diseases.
Subject of Research: Comparative pathogenicity and disease biology of two Crimean-Congo hemorrhagic fever virus isolates in IFNAR−/− mice.
Article Title: Side-by-side evaluation of two Crimean-Congo hemorrhagic fever virus isolates in IFNAR−/− mice.
Article References: Rohde, C., Werner, AD., Gellhorn Serra, M. et al. Side-by-side evaluation of two Crimean-Congo hemorrhagic fever virus isolates in IFNAR−/− mice. npj Viruses 4, 35 (2026). https://doi.org/10.1038/s44298-026-00216-2
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s44298-026-00216-2
Keywords: Crimean-Congo hemorrhagic fever virus, CCHFV, IFNAR−/− mice, viral isolates, viral pathogenesis, animal models, interferon signaling, hemorrhagic fever, antiviral research.
Tags: comparative analysis of CCHFV isolatesCrimean-Congo hemorrhagic fever virusexperimental models for hemorrhagic feverIFNAR-deficient mouse modelImmune Evasion Mechanismsinnate immunity in viral infectionsType I interferon responseviral genetic diversity and disease outcomesviral genome variabilityviral pathogenicity and tissue damageviral replication and disease severityvirus-host interactions
